Leflunomide

A summary of the most common chemical descriptors (InChI Key and SMILES codes) for Leflunomide are summarized together with 3D and 2D structures and relevant physico-chemical properties.

What is the Leflunomide?

The molecule Leflunomide presents a molecular formula of C12H9F3N2O2 and its IUPAC name is 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide.

Leflunomide (trade names Arava, among others) is an immunomodulatory disease-modifying antirheumatic drug (DMARD) used in the treatment of autoimmune diseases such as rheumatoid arthritis and psoriatic arthritis. It is a prodrug that is metabolized by the liver into the active metabolite, teriflunomide..

3D structure

Cartesian coordinates

Geometry of Leflunomide in x, y and z coordinates (Å units) to copy/paste elsewhere. Generated with Open Babel software.

2D drawing

 

Leflunomide VHOGYURTWQBHIL-UHFFFAOYSA-N chemical compound 2D structure molecule svg
Leflunomide

 

Molecule descriptors

 
IUPAC name5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
InChI codeInChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)
InChI KeyVHOGYURTWQBHIL-UHFFFAOYSA-N
SMILESCc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1

Other names (synonyms)

IUPAC nomenclature provides a standardized method for naming chemical compounds. Although this system is widely used in chemistry, many chemical compounds have also other names commonly used in different contexts. These synonyms can come from a variety of sources and are used for a variety of purposes.

One common source of synonyms for chemical compounds is the common or trivial names, assigned on the basis of appearance, properties, or origin of the molecule.

Another source of synonyms are historical or obsolete names employed in the past, however replaced nowadays by more modern or standardized names.

In addition to common and historical names, chemical compounds may also have synonyms that are specific to a particular field or industry.

  • 4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl
  • 4-Isoxazolecarboxamide, 5-methyl-N-(4-(trifluoromethyl)phenyl)-
  • 4-Isoxazolecarboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-
  • 5-Methyl-N-(4-(trifluoromethyl)phenyl)-4-isoxazolecarboxamide
  • 5-Methyl-N-[4-(trifluoromethyl)-phenyl]isoxazole-4-carboxamide
  • 5-Methylisoxazole-4-(4-trifluoromethylcarboxanilide)
  • 5-Methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
  • 5-methyl-4-(4-trifluoromethyl-phenyl)aminocarbonylisoxazole
  • 5-methyl-4-(4-trifluoromethylphenyl)aminocarbonylisoxazole
  • 5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide
  • 5-methyl-N-(4-(trifluoromethyl)phenyl)isoxazole-4-carboxamide;Leflunomide
  • 5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
  • 5-methyl-N-[4-(trifluoromethyl)phenyl]-4-isoxazolecarboxamide
  • 5-methyl-N-[4-(trifluoromethyl)phenyl]isoxazole-4-carboxamide
  • 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)-anilide
  • 706L126
  • 75706-12-6
  • A9622
  • AB00052389
  • AB00052389-17
  • AB00052389-18
  • AB00052389_19
  • AB00052389_21
  • AC-6796
  • Arabloc
  • Arava
  • BCP22241
  • BCP9000846
  • BDBM50054601
  • BIDD:PXR0189
  • BM164612
  • BPBio1_000930
  • BSPBio_000844
  • C07905
  • CCG-204736
  • CS-1781
  • D00749
  • DB01097
  • DL-433
  • DSSTox_CID_3201
  • DSSTox_GSID_23201
  • DSSTox_RID_76923
  • DivK1c_000916
  • EU-0100649
  • FT-0621959
  • G162GK9U4W
  • GTPL6825
  • HMS1570K06
  • HMS1922M06
  • HMS2090O12
  • HMS2097K06
  • HMS2235C07
  • HMS3262A19
  • HMS3268D12
  • HMS3371F21
  • HMS3414P03
  • HMS3654F07
  • HMS3673M17
  • HMS3678N21
  • HMS3714K06
  • HMS3865I13
  • HMS502N18
  • HSDB 7289
  • HWA 486
  • HWA-486
  • HWA486
  • HWA486; RS-34821; SU101;HWA 486; RS 34821; SU 101
  • HY-B0083
  • IDI1_000916
  • Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-
  • KBio1_000916
  • KBio2_000802
  • KBio2_003370
  • KBio2_005938
  • KBioSS_000802
  • KS-1076
  • L 5025
  • L0250
  • L04AA13
  • LP00649
  • Leflunomida
  • Leflunomide
  • Leflunomide (JAN/USP/INN)
  • Leflunomide ratiopharm
  • Leflunomide teva
  • Leflunomide winthrop
  • Leflunomide, Immunosuppressant
  • Leflunomidum
  • Lopac-L-5025
  • Lopac0_000649
  • MFCD00867593
  • MLS-0003109.0001
  • MLS000069648
  • MLS001076267
  • N-(4'-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
  • N-(4-(TRIFLUOROMETHYL)PHENYL) 5 METHYLISOXAZOLE-4-CARBOXAMIDE
  • N-(4-trifluoromethylphenyl)-5-methylisoxa-zole-4-carboxamide
  • N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
  • NCGC00015610-01
  • NCGC00015610-02
  • NCGC00015610-03
  • NCGC00015610-04
  • NCGC00015610-05
  • NCGC00015610-06
  • NCGC00015610-07
  • NCGC00015610-08
  • NCGC00015610-09
  • NCGC00015610-10
  • NCGC00015610-11
  • NCGC00015610-12
  • NCGC00015610-13
  • NCGC00015610-14
  • NCGC00015610-17
  • NCGC00015610-18
  • NCGC00015610-30
  • NCGC00022625-03
  • NCGC00022625-04
  • NCGC00022625-05
  • NCGC00022625-06
  • NCGC00022625-07
  • NCGC00022625-08
  • NCGC00255370-01
  • NCGC00261334-01
  • NINDS_000916
  • NSC 677411
  • NSC 759864
  • NSC-677411
  • NSC-759864
  • NSC677411
  • NSC759864
  • Opera_ID_1709
  • Pharmakon1600-01503927
  • Prestwick0_000772
  • Prestwick1_000772
  • Prestwick2_000772
  • Prestwick3_000772
  • Prestwick_87
  • Q-201289
  • Q248550
  • RS-34821
  • Repso
  • SB17287
  • SDCCGSBI-0050629.P003
  • SMR000058209
  • SPECTRUM1503927
  • SR-01000000191
  • SR-01000000191-2
  • SR-01000000191-4
  • SR-01000000191-7
  • STL426823
  • SU 101
  • SU 101 (pharmaceutical)
  • SU-101
  • SU101
  • SULOL
  • SW196399-3
  • alpha,alpha,alpha-Trifluoro-5-methyl-4-isoxazolecarboxy-p-toluidide
  • leflunomide
  • leflunomide medac
  • lefunamide
  • s1247

Reference codes for other databases

There exist several different chemical codes commonly used in orded to identify molecules:
  • ZINC4840
  • CAS-75706-12-6
  • UNII-G162GK9U4W
  • AKOS000265193
  • ALBB-019233
  • BRD-K78692225-001-03-9
  • BRD-K78692225-001-11-2
  • DTXSID9023201
  • CHEMBL960
  • CHEBI:6402
  • Tox21_110182
  • Tox21_301873
  • Tox21_500649
  • Tox21_110182_1
  • SPBio_002783
  • SCHEMBL5057
  • Spectrum_000322
  • Spectrum5_000850

Physico-Chemical properties

IUPAC name5-methyl-N-[4-(trifluoromethyl)phenyl]-1,2-oxazole-4-carboxamide
Molecular formulaC12H9F3N2O2
Molecular weight270.207
Melting point (ºC)
Boiling point (ºC)
Density (g/cm3)
Molar refractivity60.69
LogP3.3
Topological polar surface area55.1

LogP and topological polar surface area (TPSA) values were estimated using Open Babel software.

The n-octanol/water partition coeficient (Kow) data is applied in toxicology and drug research. Kow values are used, to guess the environmental fate of persistent organic pollutants. High partition coefficients values, tend to accumulate in the fatty tissue of organisms. Molecules with a log(Kow) (or LogP) greater than 5 are considered to bioaccumulate.

TPSA values are the sum of the surface area over all polar atoms or molecules, mainly oxygen and nitrogen, also including hydrogen atoms.

In medicinal chemistry, TPSA is used to assess the ability of a drug to permeabilise cells.

For molecules to penetrate the blood-brain barrier (and act on receptors in the central nervous system), TPSA values below 90 Å2 are required. Thus, molecules with a polar surface area greater than 140 Å2 tend to be poorly permeable to cell membranes.